A Phase 1 Open-Label, Multi-Center, Safety and Efficacy Study of PRT2527 as Monotherapy and in Combination with Zanubrutinib in Participants with Relapsed/Refractory Hematologic Malignancies

Gregory, Gareth (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Project Description

NMA/ERM Reference Number: 96851
Monash Health Reference: RES-23-0000-494X

Status	Active
Effective start/end date	31/08/23 → 30/08/28